Metastases clinical trials at University of California Health

3 in progress, 2 open to eligible people

Showing trials for

  • REMASTer: REcurrent Brain Metastases After SRS Trial

    open to eligible people ages 18 years and up

    Randomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for radiographic progression after stereotactic radiosurgery (SRS), with or without surgery.

    at UCLA

  • EchoTip AcuCore Post-Market Clinical Study

    open to eligible people ages 18 years and up

    The purpose of collecting this data is to continue to learn more about the EchoTip AcuCore and the device's ability to produce the desired favorable effect and if there are any undesired outcomes that may be related to the EchoTip AcuCore.

    at UC Irvine

  • Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

    Sorry, in progress, not accepting new patients

    A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes

    at UCLA UCSF

Our lead scientists for Metastases research studies include .

Last updated: